Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib

Ibrutinib is associated with bleeding-related adverse events of grade ≤2 in severity, and infrequently with grade ≥3 events. To investigate the mechanisms of bleeding and identify patients at risk, we prospectively assessed platelet function and coagulation factors in our investigator-initiated tria...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Haematologica
Egile Nagusiak: Lipsky, Andrew H., Farooqui, Mohammed Z.H., Tian, Xin, Martyr, Sabrina, Cullinane, Ann M., Nghiem, Khanh, Sun, Clare, Valdez, Janet, Niemann, Carsten U., Herman, Sarah E. M., Saba, Nakhle, Soto, Susan, Marti, Gerald, Uzel, Gulbu, Holland, Steve M., Lozier, Jay N., Wiestner, Adrian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ferrata Storti Foundation 2015
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4666333/
https://ncbi.nlm.nih.gov/pubmed/26430171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.126672
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak